Related Experiment Videos
Intracavernosal injection and intraurethral therapy for erectile dysfunction
S Leungwattanakij1, V Flynn, W J Hellstrom
1Department of Urology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
The Urologic Clinics of North America
|June 14, 2001
Summary
Oral therapies are the first-line treatment for erectile dysfunction due to effectiveness and minimal side effects. Alternative intracavernosal and intraurethral treatments remain valuable options when oral medications are ineffective or contraindicated.
Area of Science:
- Urology
- Pharmacology
Background:
- Oral therapies are the primary treatment for erectile dysfunction (ED).
- Intracavernosal and intraurethral treatments are established therapeutic options for ED.
- The development of novel oral ED treatments continues.
Purpose of the Study:
- To review the current landscape of ED treatments.
- To highlight the role of oral, intracavernosal, and intraurethral therapies in ED management.
- To discuss treatment algorithms and patient selection.
Main Methods:
- Literature review of existing studies on ED therapies.
- Analysis of treatment efficacy and side effect profiles.
- Discussion of clinical guidelines and expert opinions.
Main Results:
- Oral therapies are effective with minimal side effects and are recommended as first-line treatment for ED.
- Intracavernosal and intraurethral treatments are viable alternatives when oral therapies fail or are contraindicated.
- Sildenafil demonstrated success in 56-57% of patients who previously failed other ED treatments.
Conclusions:
- Oral medications, intracavernosal injections, and intraurethral therapies are all essential components of ED treatment.
- Treatment choice depends on patient factors, including efficacy, side effects, and contraindications.
- A stepwise approach to ED management ensures optimal patient outcomes.